Early goal-directed therapy reduced mortality and multiorgan dysfunction in severe sepsis or septic shock

Natanson, Charles; Danner, Robert L.
May 2002
ACP Journal Club;May/Jun2002, Vol. 136 Issue 3, p90
Academic Journal
Comments on a study which examined early goal-directed therapy in the treatment of severe sepsis and septic shock. Outcome measures; Occurrence of death attributable to sudden cardiovascular collapse in the early goal-directed therapy (EGDT) group; Benefits of EGDT to patients with severe sepsis or septic shock.


Related Articles

  • Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock. Rivers, Emanuel; Nguyen, Bryant; Havstad, Suzanne; Ressler, Julie; Muzzin, Alexandria; Knoblich, Bernhard; Peterson, Edward; Tomlanovich, Michael // New England Journal of Medicine;11/8/2001, Vol. 345 Issue 19, p1368 

    Background: Goal-directed therapy has been used for severe sepsis and septic shock in the intensive care unit. This approach involves adjustments of cardiac preload, afterload, and contractility to balance oxygen delivery with oxygen demand. The purpose of this study was to evaluate the efficacy...

  • Current strategies for managing the patient with sepsis. Kuhl, David A. // American Journal of Health-System Pharmacy;2/15/2002, Vol. 59 Issue 4, pS9 

    A patient with sepsis is likely to have symptoms characteristic of the systemic inflammatory response syndrome. Initially, ruling out noninfective causes, locating the site of infection, and obtaining cultures before beginning antimicrobial therapy are critical. Aggressive fluid resuscitation...

  • Innovative Therapies for Sepsis. Krishnagopalan, S.; dellinger, R.P. // BioDrugs;2001, Vol. 15 Issue 10, p645 

    Sepsis and septic shock continue to be a major cause of morbidity and mortality. Despite numerous advances in the supportive care of patients with sepsis, the overall mortality has changed little in the past 20 years. Many innovative therapies have been attempted in the field of sepsis,...

  • Anandamide absorption by direct hemoperfusion with polymixin B-immobilized fiber improves the prognosis and organ failure assessment score in patients with sepsis. Kohro, Shinji; Imaizumi, Hitoshi; Yamakage, Michiaki; Masuda, Yoshiki; Namiki, Akiyoshi; Asai, Yasuhumi; Maruyama, Ikuo // Journal of Anesthesia;2006, Vol. 20 Issue 1, p11 

    The article presents a study which aims to clarify the mechanism of PMX-DHP effect on septic shock. The study was conducted at conducted at Sapporo Medical University and three community hospitals in Japan from January 2000 to December 2002. Treatments including regular antibiotic therapy were...

  • Corticosteroids in the Treatment of Severe Sepsis and Septic Shock in Adults. Annane, Djillali; Bellissant, Eric; Bollaert, Pierre-Edouard; Briegel, Josef; Confalonieri, Marco; De Gaudio, Raffaele; Keh, Didier; Kupfer, Yizhak; Oppert, Michael; Meduri, G. Umberto // JAMA: Journal of the American Medical Association;6/10/2009, Vol. 301 Issue 22, p2362 

    The article discusses a study which investigated the risks and benefits of corticosteroid treatment in severe sepsis and septic shock. The study included 17 randomized and quasi-randomized trials of corticosteroids compared to placebo in adult patients. In 12 trials, study authors found that...

  • Discovery and Development of Toll-Like Receptor 4 (TLR4) Antagonists: A New Paradigm for Treating Sepsis and Other Diseases. Carlos Leon; Jessica Jia; Olena Sivak; Kishor Wasan // Pharmaceutical Research;Aug2008, Vol. 25 Issue 8, p1751 

    Abstract Abstract  Sepsis remains the most common cause of death in intensive care units in the USA, with a current estimate of at least 750,000 cases per year, and 215,000 deaths annually. Despite extensive research still we do not quite understand the cellular and molecular mechanisms...

  • Monoclonal antibodies in sepsis and septic shock. Hinds, C.J. // BMJ: British Medical Journal (International Edition);1/18/92, Vol. 304 Issue 6820, p132 

    Examines the efficacy of monoclonal antibodies as treatment for sepsis and septic shock. Effects of monoclonal antibodies to laboratory animals; Treatment directed against circulating endotoxins; Contributions to improving the outcome of life threatening infections.

  • A revival for immunoglobulin therapy in septic shock? Textoris, Julien; Calandra, Thierry; Pène, Frédéric // Intensive Care Medicine;Dec2014, Vol. 40 Issue 12, p1957 

    The article explores the utilization of immunoglobulins in the treatment of septic shock. The therapeutic potential of polyvalent intravenous immunoglobulin (IVIG) preparations in septic patients is highlighted. The authors review a study which failed to identify any significant baseline...

  • Early goal-directed therapy versus 'early', 'goal-directed' therapy. Saleh, Ahmad // Intensive Care Medicine;Sep2015, Vol. 41 Issue 9, p1723 

    A letter to the editor is presented in response to the article "A Systematic Review and Meta-analysis of Early Goal-directed Therapy for Septic Shock: The ARISE, ProCESS and ProMISe Investigators" by D. C. Angus and colleagues in the 2015 issue.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics